Joint call for proposals between ANRS MIE and DZIF on HIV, hepatitis B, and hepatitis Delta cure

The call will open on 26 October 2026 and applications may be submitted until 12 January 2027.

Last updated on 16 October 2026

Main points

  • The French National Research Agency for HIV, Viral Hepatitis and Emerging Infectious Diseases (ANRS MIE) and the German Center for Infection Research (DZIF) are launching a joint call for proposals to contribute to translational and preclinical research on cures for HIV, hepatitis B (HBV) and hepatitis Delta (HDV).
  • Contributing to research on HIV and hepatitis cures is a common strategic priority.
  • The total budget allocated to this joint call is €2 million. Up to four projects may be funded: two projects focused on HIV and two projects focused on viral hepatitis.

Why a joint call for proposals?

This call is part of a shared commitment to strengthening scientific collaborations between France and Germany, which have a long-standing tradition of scientific and academic cooperation. By bringing together ANRS MIE and DZIF around converging scientific priorities, it aims to create a Franco-German research dynamic and foster synergies between teams on the issue of cure, particularly in the field of HIV and hepatitis B and Delta. Projects submitted under this call for proposals must therefore involve at least one French research team and one German research team from a DZIF member institution or a DZIF-associated partner, acting as co-leading teams of the project.

Interview with Prof. Maura Dandri (DZIF) and Prof. Yazdan Yazdanpanah (ANRS MIE)

Prof. Maura Dandri (MD), coordinator of the “Hepatitis” research area, DZIF and Prof. Yazdan Yazdanpanah (YY), Director, ANRS MIE

What is the history of collaboration between ANRS MIE and DZIF?

MD and YY : The collaboration between ANRS MIE and DZIF is part of a long-standing relationship, formalized as early as 2014 through a first memorandum of understanding focused on HIV/AIDS and hepatitis B. In 2023, this partnership was renewed and expanded to cover a broader field of infectious diseases, including HIV, viral hepatitis, tuberculosis and emerging infectious diseases.

This cooperation framework aims in particular to promote the joint identification of scientific priorities, the development of joint research programs, participation in scientific events and working groups, including promoting a joint training of the next generation of scientists in infection research, as well as information sharing and the dissemination of research results.